The global market for pharma-grade synthetic camphor is on an upward trajectory, with projections indicating a rise from USD 449.3 million in 2024 to USD 652.4 million by 2034. This represents a compound annual growth rate (CAGR) of 3.8% over the forecast period between 2024 and 2034. In 2023, the revenue from pharma-grade synthetic camphor was USD 432.8 million, marking a strong year of growth for this essential compound.
The sustained growth in the pharma-grade synthetic camphor market can be attributed to its diverse applications within the pharmaceutical and healthcare industries. As a key ingredient derived from chemical synthesis, synthetic camphor has proven its value in both therapeutic and over-the-counter (OTC) products. With properties that include analgesic, anti-inflammatory, and antimicrobial effects, pharma-grade synthetic camphor plays a vital role in improving patient care.
Its widespread use in topical formulations, as well as in respiratory products, underscores its significance. This versatile compound is increasingly incorporated into a variety of pharmaceutical applications, contributing to the market’s expansion.
As the demand for effective, multi-purpose pharmaceutical ingredients continues to grow, pharma-grade synthetic camphor remains a cornerstone of innovation in the industry, supporting the development of both existing and new therapies.
Key Takeaways:
- The global sales of pharma-grade synthetic camphor are projected to reach USD 449.3 million in 2024, with an estimated growth to USD 652.4 million by 2034, reflecting a compound annual growth rate (CAGR) of 3.8% during the forecast period.
- In 2023, the pharma-grade synthetic camphor market generated USD 432.8 million in revenue.
Key regions are expected to demonstrate varying growth rates:
-
- USA: Expected to show a modest 1.2% CAGR from 2024 to 2034.
- Germany: Projected to exhibit a 1.3% CAGR over the forecast period.
- China: Predicted to lead with a strong 3.8% CAGR.
- France: Anticipated to experience a 1.9% CAGR.
- India: Expected to see the highest growth at 4.3% CAGR.
- Spain: Forecasted to grow at a 2.2% CAGR.
- Australia: Expected to grow at 1.7% CAGR.
- South Korea: Projected to witness a 3.0% CAGR.
- Overall, the market is expected to continue its steady expansion, driven by consistent demand across both established and emerging markets.
“The continued growth of the pharma grade synthetic camphor market can be attributed to the increasing recognition of its therapeutic benefits, particularly in pain relief and inflammation reduction. As the healthcare industry evolves, the demand for multifunctional ingredients such as synthetic camphor, with its analgesic, anti-inflammatory, and antimicrobial properties, will continue to drive market growth. The rising prevalence of chronic conditions that require long-term topical and respiratory treatments also contributes to the expanding use of synthetic camphor in pharmaceutical formulations.” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
High Demand for Pharma Grade Synthetic Camphor: Uncover the Trends and Insights with Our Detailed Report!
Competitive Landscape:
Market players are employing various strategies to maintain competitiveness, including product differentiation through innovative formulations and forging strategic partnerships with healthcare providers for improved distribution. A key focus for these companies is actively seeking strategic partners to enhance their product portfolios and expand their presence in global markets.
Recent Industry Developments in the Pharma-Grade Synthetic Camphor Market
- In July 2024, Mangalaim Organics Limited acquired the remaining 10% stake in Mangalam Pooja Stores Private Limited from Sandeep Shriya for INR 0.1 million.
- Saptagir Camphor Limited is expanding its market footprint by prioritizing the production of high-quality synthetic camphor. As of July 1, 2024, the company stands to benefit from the overall market growth, fueled by increasing demand in pharmaceuticals and personal care products.
Key Players of Pharma Grade Synthetic Camphor Market:
- Merck KGaA
- Oriental Aromatics Limited
- Saptagir Camphor Limited
- Mangalam Organics Limited
- Nippon Fine Chemical Co., Ltd.
- Rochem International, Inc.
- Spectrum Chemical Mfg. Corp.
- Aldon Corporation
- Prinova Group LLC.
- Fengchen Group Co., Ltd
Key Segments of Pharma Grade Synthetic Camphor Market
By Formulation Type:
In terms of formulation type, the industry is divided into topical and inhalation.
By Application:
In terms of application, the industry is segregated into respiratory disorders, muscular rheumatism, counterirritant and antipruritic and others
By Distribution Channels:
In terms of distribution channels, the industry is segregated into conventional B2B (tenders, direct procurement, wholesalers & distributors) and online B2B (internal channel, external channel)
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain:
The USA compounding pharmacies market size was projected to be worth USD 10,326.0 million in 2022. By the end of 2023, the market is likely to reach a valuation of USD 11,099.0 million. The global market for USA Compounding Pharmacies is likely to garner a 7.8% CAGR and reach a market worth USD 23,430.35 million by 2033.
The global antibiotics active pharmaceutical ingredient (API) market share is expected to attain a valuation of USD 8653.0 million in 2023 and is projected to reach USD 12002.3 million by 2033, trailing a CAGR of 3.3% during the forecast period.
According to Future Market Insights (FMI), the oxytocic pharmaceuticals market demand is likely to generate USD 114.58 million in revenue in 2023. The oxytocic pharmaceuticals industry is anticipated to thrive at a 7.8% CAGR from 2023 to 2033, reaching USD 242.83 million by 2033.
The global hyaluronic acid products market growth is expected to attain a valuation of USD 3,343.5 million in 2023 and is projected to reach USD 6,838.2 million by 2033, rising at a CAGR of 7.4% during the forecast period.
The aromatherapy market trends is expected to be valued at USD 7,048.0 million in 2024. The pace of progress for the market from 2024 to 2034 is expected to be encouraging, with a CAGR of 6.4%. By the end of the forecast period, the aromatherapy industry value is slated to hit USD 13,106.40 million.
The global canine atopic dermatitis treatment market forecast expects a considerable valuation bump, from USD 1,182.60 million in 2024 to USD 1,620.50 million in 2034. The updated report points to a CAGR of 3.20% CAGR from 2024 to 2034.
The global atopic dermatitis treatment market overview is estimated to be worth USD 15,048.6 million in 2024 and anticipated to reach a value of USD 45,501.6 million by 2034. Sales are projected to rise at a CAGR of 11.7% over the forecast period between 2024 and 2034.
The global sales of cartilage repair is estimated to be worth USD 1,474.6 million in 2024 and anticipated to reach a value of USD 2,767.9 million by 2034. Sales are projected to rise at a CAGR of 6.5% over the forecast period between 2024 and 2034.
The global contrast media injectors market development is estimated to be worth USD 4,949 million in 2024 and anticipated to reach a value of USD 8,832.8 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034.
The global reagent filling systems market outlook are estimated to be worth USD 10,253.6 million in 2024 and anticipated to reach a value of USD 18,190.1 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube